Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, Italy.
Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste, Italy.
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
SUMMARY infection (CDI) is one of the major issues in nosocomial infections. This bacterium is constantly evolving and poses complex challenges for clinicians, often encountered in real-life scenarios. In the face of CDI, we are increasingly equipped with new therapeutic strategies, such as monoclonal antibodies and live biotherapeutic products, which need to be thoroughly understood to fully harness their benefits. Moreover, interesting options are currently under study for the future, including bacteriophages, vaccines, and antibiotic inhibitors. Surveillance and prevention strategies continue to play a pivotal role in limiting the spread of the infection. In this review, we aim to provide the reader with a comprehensive overview of epidemiological aspects, predisposing factors, clinical manifestations, diagnostic tools, and current and future prophylactic and therapeutic options for infection.
艰难梭菌感染(CDI)是医院获得性感染的主要问题之一。这种细菌在不断进化,给临床医生带来了复杂的挑战,在现实生活中经常遇到。面对 CDI,我们越来越多地配备了新的治疗策略,如单克隆抗体和活体生物治疗产品,需要彻底了解这些策略,以充分发挥它们的优势。此外,目前正在研究未来的有趣选择,包括噬菌体、疫苗和抗生素抑制剂。监测和预防策略继续在限制感染传播方面发挥着关键作用。在这篇综述中,我们旨在为读者提供艰难梭菌感染的流行病学方面、易患因素、临床表现、诊断工具以及当前和未来的预防和治疗选择的全面概述。